Trial intelligence / Profile preview

TJ-14 vs loperamide for acute radiation-induced enteritis

jRCT1041190050Phase 3Recruiting

Sponsor
Research Foundation of Oriental Medicine
Start
Mar 2020
Countries
1
01

Overview

Phase 3, randomised trial of hangeshashinto in enteritis and radiation enteritis (2 arms), sponsored by Research Foundation of Oriental Medicine. Primary endpoint: Patient-reported diarrhea outcome at 1 week. Started Mar 2020; status: recruiting.

02

Drugs

hangeshashinto
03

Conditions

enteritisradiation enteritis

Beyond the preview

Go deeper on jRCT1041190050.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1041190050.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call